Intestinal sodium/glucose cotransporter 3 expression is epithelial and downregulated in obesity-Reference-Cited by-同舟云学术

Intestinal sodium/glucose cotransporter 3 expression is epithelial and downregulated in obesity

Published:2021-02 Issue: Volume:267 Page:118974
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Soták Matúš,Casselbrant Anna,Rath Eva,Zietek Tamara,Strömstedt Maria,Adingupu Damilola D.,Karlsson Daniel,Fritsch Fredin Maria,Ergang Peter,Pácha Jiří,Batorsky Anna,Alpers Charles E.,Börgeson Emma,Hansen Pernille B.L.,Ericsson Anette,Björnson Granqvist Anna,Wallenius Ville,Fändriks Lars,Unwin Robert J.

Funder

AstraZeneca

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference63 articles.

1. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013;Ng;Lancet,2014

2. Expression of monosaccharide transporters in intestine of diabetic humans;Dyer;Am. J. Physiol. Liver Physiol.,2002

3. Glucose absorption in small intestinal diseases;Thazhath;Expert Rev. Gastroenterol. Hepatol.,2014

4. The Na+-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer;Koepsell;Pharmacol. Ther.,2017

5. Combination therapy for obesity;Wilding;J. Psychopharmacol.,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relationship between SGLT2 and systemic blood pressure regulation;Hypertension Research;2024-05-23

2. Sodium-Glucose Cotransporter 2 Inhibitors' Mechanism of Action and Use in Kidney Transplantation Recipients: Extended Review and Update;Journal of Diabetes and Endocrine Practice;2024-04

3. The SGLT family—sodium‐glucose transporters with roles beyond glucose and the kidney;Journal of Cellular and Molecular Medicine;2024-03

4. Sex-Dependent Changes to the Intestinal and Hepatic Abundance of Drug Transporters and Metabolizing Enzymes in the SOD1^G93A Mouse Model of Amyotrophic Lateral Sclerosis;Molecular Pharmaceutics;2024-02-28

5. Human intestinal organoids: Modeling gastrointestinal physiology and immunopathology — current applications and limitations;European Journal of Immunology;2023-11-28